Susquehanna Fundamental Investments’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Susquehanna Fundamental Investments's RGEN Position: Q2 2025 in Review
Susquehanna Fundamental Investments sold out of Repligen (RGEN) in Q2 2025, closing a stake of 4,000 shares — an estimated $509K sold.
Susquehanna Fundamental Investments first reported a position in RGEN in Q2 2020 and held it in 12 quarters. The position peaked at $11.6M in Q3 2022. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.
- Susquehanna Fundamental Investments reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
- Susquehanna Fundamental Investments sold 4,000 Repligen shares in Q2 2025, an estimated $509K.
- Susquehanna Fundamental Investments first reported a position in Repligen in Q2 2020 and held it in 12 quarters.
- Susquehanna Fundamental Investments's Repligen position peaked at $11.6M in Q3 2022.
- 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.
Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.